Researchers have found that adults who stop taking GLP-1 receptor agonist drugs such as semaglutide and tirzepatide face a measurable increase in heart attack, stroke, and death risk within months of ...

Objective To evaluate the safety and durability of telitacicept treatment in patients with SLE by identifying the reasons for ...

Wrapping dehydrated human amniotic membrane around nerve and anastomotic tissue during robotic prostatectomy was associated ...

Methods: This retrospective multicenter cohort study analyzed electronic health record data from 3 hospitals in South Korea. AKI and AKD were defined using a refined version of the Kidney Disease: ...

A real-world analysis of patients receiving teclistamab prior to 2022 showed comparable outcomes to clinical trials and ...

Exposure to secondhand smoke is linked to many adverse pediatric health outcomes. Well-child visits can be an opportunity to ...

A peer-reviewed analysis of U.S. adverse event data has found that patients taking Wegovy face nearly five times the risk of ...

Dr Ray O’Connor takes a look at the latest clinical studies on dementia, including its diagnosis and management ...

GLP-1 receptor agonist drugs may be the weight loss approach that better addresses their arrhythmia, observational data s ...

Data are early, retrospective, and unlikely to influence guidelines, but interest among operators is growing, says Sameh Sayfo.

In patients with OSA, increased subjective sleepiness based on ESS scores is associated with higher short-term CPAP adherence.

Patients adherent to SUBLOCADE ® for 12 months had 42% lower adjusted non-MOUD medical costs vs. those adherent to other forms of MOUD; Patients adherent to SUBLOCADE had the low ...